Literature DB >> 11572138

Clinicopathologic features of viral agents of potential use by bioterrorists.

T H Burgess1, K E Steele, B A Schoneboom, F B Grieder.   

Abstract

Concerns regarding the possible use of viral agents as weapons of mass destruction have heightened our need to recognize disease syndromes caused by these pathogens and to increase our understanding of potential countermeasures. This article reviews the clinical and pathologic features of various viruses that are generally thought to be potential biowarfare threats, and other related agents of topical interest. The epidemiologic and clinical aspects of recent natural outbreaks of disease caused by exotic viral agents are briefly described. Viral tissue targets, immune responses to these agents, relevant animal models, and diagnostic and potential therapeutic modalities also are discussed.

Mesh:

Year:  2001        PMID: 11572138

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  4 in total

1.  Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses.

Authors:  Kate D Ryman; Christina L Gardner; Crystal W Burke; Kathryn C Meier; Joseph M Thompson; William B Klimstra
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

2.  Sindbis virus translation is inhibited by a PKR/RNase L-independent effector induced by alpha/beta interferon priming of dendritic cells.

Authors:  K D Ryman; K C Meier; E M Nangle; S L Ragsdale; N L Korneeva; R E Rhoads; M R MacDonald; W B Klimstra
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Identification and characterization of interferon-induced proteins that inhibit alphavirus replication.

Authors:  Yugen Zhang; Crystal W Burke; Kate D Ryman; William B Klimstra
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

4.  Specific nucleotide changes in the subgenomic promoter region influence infectivity of the sindbis virus.

Authors:  W-Y Zhu; T Zhao; G-D Liang
Journal:  Intervirology       Date:  2013-07-03       Impact factor: 1.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.